Amanote Research

Amanote Research

    RegisterSign In

Reslizumab in the Management of Poorly Controlled Asthma: The Data So Far

Journal of Asthma and Allergy - New Zealand
doi 10.2147/jaa.s94164
Full Text
Open PDF
Abstract

Available in full text

Categories
ImmunologyPulmonaryAllergyRespiratory Medicine
Date

August 1, 2016

Authors
Diego MaselliMaria VelezLinda Rogers
Publisher

Informa UK Limited


Related search

Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

The Story So Far…

Nature
Multidisciplinary
2000English

Trigger Recognition and Management in Poorly Controlled Asthmatics

Allergy and Asthma Proceedings
MedicineImmunologyPulmonaryAllergyRespiratory Medicine
2010English

Biosensors in Immunology: The Story So Far

Immunology Today
1997English

The Story So Far: Cell Biology

Journal of Cell Science
Cell Biology
2002English

A Sputum 6 Gene Signature Predicts Future Exacerbations of Poorly Controlled Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

ADAMTS-5: The Story So Far

2008English

Innovation in the Classroom: The JMU Experience...So Far

Journal of Strategic Security
SociologySafety ResearchLawInternational RelationsPolitical Science
2013English

Pharmacoeconomic Analysis of Therapy With Reslizumab in Severe Eosinophilic Asthma

Pulmonologiya
PulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy